These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7145885)

  • 1. [Diabetogenic factor in the blood plasma in diabetes mellitus].
    Kudriashov BA; Ponasenkova GV; Pytel' IuA
    Probl Endokrinol (Mosk); 1982; 28(5):61-4. PubMed ID: 7145885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nature of the diabetogenic factor of blood plasma in clinical and experimental diabetes].
    Kudriashov BA; Liapina LA; Ul'ianov AM
    Probl Endokrinol (Mosk); 1985; 31(6):51-3. PubMed ID: 4088993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Complex-formation of heparin with the plasma diabetogenic factor].
    Kudriashov BA; Liapina LA
    Vopr Med Khim; 1986; 32(2):64-5. PubMed ID: 3705518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Functional changes in the state of the insular system of animals after intravenous administration of diabetogenic factor].
    Kudriashov BA; Ul'ianov AM; Liapina LA
    Vopr Med Khim; 1986; 32(5):57-9. PubMed ID: 3535246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The significance of an increased protein and fat content in the food ration of rats for the development of stable alloxan diabetes].
    Ul'ianov AM; Tarasov IuA
    Probl Endokrinol (Mosk); 1989; 35(6):78-81. PubMed ID: 2622891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental analysis of the pathophysiological significance of the "diabetogenic factor" present in the blood of animals with alloxan diabetes].
    Baskakova GM; Kudriashov BA; Pytel' IuA
    Probl Endokrinol (Mosk); 1981; 27(4):42-5. PubMed ID: 7027248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stable reduction of endogenous insulin production in the body in experimental insulin-dependent diabetes].
    Kudriashov BA; Ul'ianov AM
    Vopr Med Khim; 1991; 37(4):40-3. PubMed ID: 1750208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of the pancreas in the appearance of the diabetogenic factor during the development of alloxan diabetes].
    Kudriashov BA; Tarasov IuA; Ul'ianov AM
    Patol Fiziol Eksp Ter; 1989; (3):75-9. PubMed ID: 2797907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Natural diabetogenic factor].
    Kudriashov BA
    Sov Med; 1989; (7):51-4. PubMed ID: 2678523
    [No Abstract]   [Full Text] [Related]  

  • 10. [The role of endogenous heparin in the protection against risk factors causing experimental diabetes].
    Kudriashov BA; Ul'ianov AM; Tarasov IuA
    Vopr Med Khim; 1989; 35(6):80-2. PubMed ID: 2629244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of the diabetogenic factor in the activation of the blood coagulation system in experimental alloxan diabetes].
    Kudriashov BA; Ul'ianov AM; Liapina LA
    Patol Fiziol Eksp Ter; 1986; (4):44-7. PubMed ID: 3797076
    [No Abstract]   [Full Text] [Related]  

  • 12. [Role of the diabetogenic factor in hypercoagulation of the blood].
    Kudriashov BA; Liapina LA; Ul'ianov AM
    Fiziol Zh SSSR Im I M Sechenova; 1986 Mar; 72(3):373-6. PubMed ID: 3709867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Physicochemical properties of the diabetogenic factor and its complex with heparin].
    Kudriashov BA; Ammosova IaM; Liapina LA; Ul'ianov AM
    Farmakol Toksikol; 1987; 50(3):49-52. PubMed ID: 3609278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quantitative evaluation of the sensitivity of experimental animals to the diabetogenic effect of alloxan].
    Pal'chikova NA; Seliatitskaia VG; Shorin IuP
    Probl Endokrinol (Mosk); 1987; 33(4):65-8. PubMed ID: 3658953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Age-related characteristics of the manifestation of the diabetogenic factor in the blood of animals maintained on natural and atherogenic diets].
    Kudriashov BA; Ul'ianov AM; Bazaz'ian GG; Pytel' IuA
    Probl Endokrinol (Mosk); 1984; 30(2):65-70. PubMed ID: 6718336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment effect of magnesium on alloxan induced hyperglycemia in rats.
    Ige OA; Adewoye EO; Olaleye SB; Salami AT
    Afr J Med Med Sci; 2010 Dec; 39 Suppl():103-7. PubMed ID: 22416651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Animal sensitivity to the diabetogenic action of alloxan during cold adaptation].
    Shorin IuP; Seliatitskaia VG; Nepomniashchikh GI; Pal'chikova NA; Khodova RR
    Biull Eksp Biol Med; 1984 Aug; 98(8):240-2. PubMed ID: 6466864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Isolation and various physico-chemical properties of diabetogenic factor from the blood of patients with diabetes].
    Kudriashov BA; Liapina LA; Azieva LD
    Vopr Med Khim; 1989; 35(6):63-6. PubMed ID: 2629241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antidiabetogenic action of heparin during its oral administration].
    Ul'ianov AM; Tarasov IuA
    Patol Fiziol Eksp Ter; 1996; (1):21-3. PubMed ID: 8657446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in the diabetogenic factor activity in the blood plasma of children with diabetes mellitus resulting from systematic heparin administration].
    Kudriashov BA; Zhukovskiĭ MA; Shcherbacheva LN; Ul'ianov AM; Bazaz'ian GG
    Pediatriia; 1985 Aug; (8):46-7. PubMed ID: 4069883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.